Logo Logo
Help
Contact
Switch Language to German

Ravaud, A.; Motzer, R. J.; Pandha, H. S.; Staehler, M.; George, D.; Pantuck, A. J.; Patel, A.; Chang, Y.-H.; Escudier, B.; Donskov, F.; Magheli, A.; Carteni, G.; Laguerre, B.; Tomczak, P.; Breza, J.; Gerletti, P.; Lin, X.; Lechuga, M.; Martini, J.-F. and Patard, J.-J. (2016): Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC). In: Annals of Oncology, Vol. 27

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item